Transition to targeted transperineal prostate biopsies does not impact progression to curative treatment for patients initially entered into active surveillance
Using targeted transperineal biopsy of the index lesion(s) alone does not lead to increased treatment of patients included in active surveillance.
Authors
- Patrick Juliebø‐Jones (ORCID: https://orcid.org/0000-0003-4253-1283)
- Christian Arvei Moen (ORCID: https://orcid.org/0000-0002-8356-0526)
- Alfred Honoré (ORCID: https://orcid.org/0000-0003-0420-2585)
- Christian Beisland (ORCID: https://orcid.org/0000-0002-3216-4937)
- Lars A. R. Reisæter (ORCID: https://orcid.org/0000-0002-1242-1502)
- Karsten Gravdal (ORCID: https://orcid.org/0009-0004-5914-0515)
Institutions
- Haukeland University Hospital (NO)
- University of Bergen (NO)
Publication Details
- Journal
- Urologia Journal
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1177/03915603251395510
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00